Literature DB >> 17592526

Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene.

Nan Gao1, Yao-Hua Li, Xin Li, Shun Yu, Gui-Lian Fu, Biao Chen.   

Abstract

OBJECTIVE: To approach the associated mechanism by which alpha-synuclein (alpha-Syn) might regulate the metabolism of dopamine.
METHODS: A DNA fragment, located at -495 to +25 of the human tyrosine hydroxylase (TH) gene, was amplified by PCR and inserted into the pGL(3)-Basic luciferase reporter vector. The recombinant plasmid pGL(3)-THprom was transfected into a dopaminergic cell line MES23.5 or a alpha-Syn over-expressed MES23.5 (named MES23.5/halpha-Syn(+)). The promoter activity was detected by the Dual Luciferase Assay System.
RESULTS: The luciferase activities in the MES23.5 cells transfected with pGL(3)-Basic, pGL(3)-THprom, and pGL(3)-Control vectors were 5.60+/-0.67, 26.80+/-4.11, and 32.90+/-4.75, respectively. On the other hand, the luciferase activity of pGL(3)-THprom in the MES23.5 (26.80+/-4.11) was significantly higher than that in the MES23.5/halpha-Syn(+) (14.40+/-0.61) (P<0.01).
CONCLUSION: These results indicate that the - 495 to +25 region in the TH gene possesses promoter activity for controlling the gene expression, and that alpha-Syn may negatively regulate the metabolism of dopamine by affecting the function of TH promoter as a trans-acting factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592526      PMCID: PMC5550569          DOI: 10.1007/s12264-007-0008-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  16 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

2.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  The tissue-specific methylation of the human tyrosine hydroxylase gene reveals new regulatory elements in the first exon.

Authors:  Tamás Arányi; Baptiste A Faucheux; Olfa Khalfallah; Guilan Vodjdani; Nicole Faucon Biguet; Jacques Mallet; Rolando Meloni
Journal:  J Neurochem       Date:  2005-07       Impact factor: 5.372

6.  A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Authors:  Ruth G Perez; Jack C Waymire; Eva Lin; Jen J Liu; Fengli Guo; Michael J Zigmond
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.

Authors:  P Ibáñez; A-M Bonnet; B Débarges; E Lohmann; F Tison; P Pollak; Y Agid; A Dürr; A Brice
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

8.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

9.  Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.

Authors:  Shun Yu; Xiaohong Zuo; Yaohua Li; Chen Zhang; Ming Zhou; Yu Alex Zhang; Kenji Uéda; Piu Chan
Journal:  Neurosci Lett       Date:  2004-08-26       Impact factor: 3.046

Review 10.  The synucleins.

Authors:  Julia M George
Journal:  Genome Biol       Date:  2001-12-20       Impact factor: 13.583

View more
  10 in total

1.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

Review 2.  A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer.

Authors:  Akira Nakashima; Akira Ota; Yoko S Kaneko; Keiji Mori; Hiroshi Nagasaki; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2012-05-27       Impact factor: 3.575

Review 3.  Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission.

Authors:  Anand Kant Das; Rucha Pandit; Sudipta Maiti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 4.  A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

5.  Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.

Authors:  Jaya Prasanthi Rantham Prabhakara; Gwen Feist; Sarah Thomasson; Alex Thompson; Eric Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

Review 6.  α-Synuclein and dopamine at the crossroads of Parkinson's disease.

Authors:  Lara Lourenço Venda; Stephanie J Cragg; Vladimir L Buchman; Richard Wade-Martins
Journal:  Trends Neurosci       Date:  2010-10-18       Impact factor: 13.837

7.  Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.

Authors:  Jenny-Ann Phan; Kathrine Stokholm; Justyna Zareba-Paslawska; Steen Jakobsen; Kim Vang; Albert Gjedde; Anne M Landau; Marina Romero-Ramos
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 8.  Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Mol Neurosci       Date:  2017-07-10       Impact factor: 3.444

9.  Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.

Authors:  Ashish Kumar Gupta; Ruchika Pokhriyal; Uddipan Das; Mohd Imran Khan; Domada Ratna Kumar; Rishab Gupta; Rakesh Kumar Chadda; Rashmi Ramachandran; Vinay Goyal; Manjari Tripathi; Gururao Hariprasad
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-19       Impact factor: 2.570

10.  Alpha-Synuclein Clearance through Inhibiting Akt/mTOR Pathway by Microfluidic Encapsulated Induced Conjunctival MSCs in a Parkinsonian Model.

Authors:  Meysam Forouzandeh; Mohammad Reza Bigdeli; Hossein Mostafavi; Samad Nadri; Mehdi Eskandari
Journal:  Iran J Pathol       Date:  2022-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.